The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients
13 Aug 2020 11:01 AM
The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization
23 Jul 2020 9:40 AM
Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.
24 Jun 2020 9:16 AM
Team creates neutralising antibody, effective not only against all genetically divergent global HIV-1 strains, but also on latent cells.
08 May 2018 1:28 PM